Introduction
The p53 protein plays a central role in the response to genotoxic damage in some cell types. Expression of this protein is rapidly upregulated after radiation-induced DNA damage, followed by p53-induced transcriptional activation of several downstream molecules such as p21 . The p21 protein is thought to induce p53-mediated G 1 arrest through its inhibitory eects on the activity of cyclin dependent kinases (CDK) (El-Deiry et al., 1993) . In addition to its role as a G 1 cell cycle checkpoint regulator (Kuerbitz, et al., 1992) , the p53 protein is also involved in mediating apoptosis in response to radiation and cytotoxic chemotherapy (Lowe et al., 1993a; . For instance, resting thymocytes from p53-de®cient mice are relatively resistant to radiation-induced apoptosis compared to counterpart cells expressing wildtype p53 (Lowe et al., 1993b) . In addition, restoration of wildtype p53 function has been shown to induce apoptosis in several hematopoietic and epithelial cancer cell lines, including M1 murine leukemia cells (Yonish-Rouach et al., 1991; Shaw et al., 1992; Liu et al., 1994) . In M1 cells, p53-mediated apoptosis is associated with increased levels of the BAX death eector protein and decreased levels of the BCL-2 anti-apoptotic protein, thus creating a BAX : BCL-2 ratio which is known to favor apoptosis (Oltvai et al., 1993; Miyashita et al., 1994) . The presence of four consensus p53 binding sequences in the 5' untranslated region (UTR) of the BAX promoter suggests that the ability of p53 to enhance BAX expression may be related to its ability to function as a transcriptional activator of the BAX gene in some cell types (Miyashita et al., 1995) .
Interestingly, the requirement for functional p53 protein in the apoptotic response to genotoxic damage is not a universal phenomenon. For instance, cycling thymocytes from p53-de®cient mice are exquisitely sensitive to radiation-induced apoptosis (Strasser et al., 1994) , and inactivation of p53 by the HPV E6 protein does not alter the apoptotic threshold of RKO cells or human foreskin ®broblasts in response to genotoxic stress (Slichenmyer et al., 1993) . In this report, we have further investigated the relationship between wildtype p53 expression and radiosensitivity in the SW626 ovarian cancer cell line, which lacks functional p53 (Strobel et al., 1996) , and have addressed the role of BAX in this process.
Results
Expression of p53 is not sucient for induction of G 1 arrest or apoptosis in SW626 cells SW626 cells which have been previously shown to lack functional p53 (Strobel et al., 1996) were transfected with either pSV2-neo alone or with pSV2-neo in combination with pLTRp53cGval135 cDNA. The val135 p53 construct encodes a murine temperaturesensitive (ts) p53 gene which acquires wildtype function at the permissive temperature of 328C (Yonish-Rouach et al., 1991) . Two SW626 tsp53 clones (G7 and H10) were identi®ed which expressed &15-fold greater levels of p53 on immunoblot analysis (Figure 1a ) compared to baseline p53 levels in two SW626 neo-control clones (A10 and B10) and were used for subsequent studies. In order to determine the eects of wildtype p53 on the cell cycle distribution of SW626 cells, propidium iodide analysis was performed for transfectants grown at 328C for up to 72 h, with the results shown in Figure 1b . Cells were pre-cultured for 18 h at 328C prior to the start of these experiments in order to ensure wildtype function of the tsp53 mutant protein at time 0. After this pre-culture phase, cells were trypsinized and replated at sub-con¯uent density in the presence of fresh media (time 0). At 24 h, SW626 neo-control cells demonstrated an initial decrease in the fraction of cells in G 1 , associated with a corresponding increase in the S and G 2 /M cell cycle fractions. We have previously determined that this eect is due to rapid G 1 exit of SW626 cells upon culturing at sub-con¯uent density in the presence of fresh media (data not shown). Over a 3 day period, the cell cycle distribution of SW626 neocontrol cells progressively returned to baseline. SW626 tsp53 clones exhibited a similar pattern of cell cycle alterations during incubation at 328C (Figure 1b) . At times 0, 24, 48, and 72 h of incubation, the mean G 1 fraction for SW626 neo-control cells (clones A10 and B10) was 67, 16, 45, and 49%, whereas corresponding values for SW626 tsp53 clones (clones G7 and H10) were 78, 32, 44, and 49%. Thus, there was no signi®cant evidence of G 1 arrest in tsp53 clones cultured at the permissive temperature. There was also no evidence of apoptosis in tsp53 clones as determined by standard morphologic criteria (nuclear fragmentation, cytoplasmic blebbing) or by quantitation of cells containing a sub G 0 content of DNA (Figure 1b) .
Eects of p53 on radiation sensitivity and BAX expression
In order to determine the eects of wildtype p53 function on the sensitivity of SW626 to ionizing radiation, transfectants were grown at the permissive temperature for 18 h, followed by irradiation with up to 2000 rads and assessment of viability (trypan-blue exclusion) on day 3. Interestingly, no dierences were observed in the dose-response curves generated from neo-control clones versus tsp53 clones exposed to ionizing radiation over a broad dose range (Figure 2) . The LD50 values of the four clones tested ranged from 400 ± 600 rads, consistent with the levels of radioresistance observed in other epithelial cell lines (Brachman et al., 1993; McIlwrath et al., 1994) . Levels of BAX, BCL-2, and BCL-x L were next quantitated by immunoblot analysis of lysates from tsp53 clone H10 cells incubated at 328C for up to 72 h. The p21 protein was also measured as a surrogate marker for Immunoblot analysis was performed on lysates from two neo and two tsp53 clones using the PAb 240 anti p53 antibody which recognizes both human and murine p53. Clones transfected with the tsp53 construct (G7 and H10) expressed &15-fold greater levels of p53 than did neo-control clones (A10 and B10) as assessed by densitometry analysis. (b) DNA histogram analysis was performed using SW626 neo clone A10 and tsp53 clone H10 incubated at 328C for the indicated time periods. Cells were precultured for 18 h at 328C prior to the start of the experiment in order to ensure wildtype function of the tsp53 mutant protein at time 0. After pre-culture, cells were replated in fresh media at subcon¯uent density, resulting in an intitial increase in the fraction of cells entering S-phase at 24 h. No evidence for G 1 arrest or apoptosis was observed in cells expressing the temperaturesensitive p53 mutant protein (clone H10) at 328C. Similar results were observed for neo-control clone B10 and tsp53 clone G7 Figure 2 Cytotoxicity of radiation in neo-control versus tsp53 clones. Cells were incubated for 18 h at the permissive temperature, followed by radiation over a broad dose range and continued culture at 328C for 3 days. Viable cell counts were assessed by trypan blue exclusion. Data are expressed as mean+s.e.m. percent survival as assessed by duplicate measurements at each dose. There were no signi®cant dierences in the shape of the dose-response curves between neo versus tsp53-expressing clones p53 and BAX in radiation-induced apoptosis T Strobel et al p53-dependent transcriptional activation. As shown in Figure 3a , p21 was induced at 24 h and persisted throughout the 72 h incubation period only at the permissive temperature of 328C. Neo-control cells exposed to 328C under identical conditions failed to express p21, excluding a non-speci®c eect of temperature on p21 induction (data not shown). Thus, the inducible expression of p21 at 328C con®rms the presence of functional p53 in SW626 cells containing the tsp53val135 construct. Despite the presence of functional p53, however, no change was observed in the expression of BAX, BCL-2 or BCL-x L over a 72 h period at 328C (Figure 3a) . Densitometric analysis revealed no evidence for induction of BAX, or down-regulation of BCL-2 or BCL-x L , after ionizing radiation (1000 rads) over 72 h at the permissive temperature (Figure 3b ).
BAX overexpression in SW626 cells does not confer sensitivity to ionizing radiation
These data suggested that inability of p53 to upregulate BAX expression may be partly responsible for the lack of enhancement of apoptosis in SW626 cells cultured at the permissive temperature (with or without radiation). If BAX is the major downstream regulator of p53-induced apoptosis, however, we reasoned that it should be possible to bypass the need for functional p53 by constitutively overexpressing BAX. SW626 cells were transfected with a cDNA encoding murine HA-BAX, generating three clones (A9, D7, and D8) which express a mean tenfold higher BAX levels than neo-control clones A10 and B10 by immunoblot analysis (Figure 4a ). These SW626 HA-BAX clones exhibited identical morphology and growth characteristics when compared to those of neo-control clones (data not shown). In order to determine whether overexpression of BAX conferred sensitivity of SW626 cells to radiation-induced apoptosis, a dose response curve of survival as a function of radiation dose was determined by trypan-blue exclusion on day 3 after radiation. As shown in Figure 4b , SW626 cells overexpressing BAX were not more sensitive to radiation when compared to neo-control cells. Both neocontrol and HA-BAX clones demonstrated an equivalent degree of morphologic evidence of apoptosis after radiation exposure (data not shown). Analysis of the sub-G 0 content of DNA by propidium iodide staining was performed in order to quantitate the fraction of apoptotic cells in BAX overexpressors (clones D7 and A9) compared with that of neo-control cells (clones A10 and B10) at 72 h after irradiation with 2000 rads. The sub-G 0 fraction (mean+s.e.m.) for the two BAX clones (33.2+1%) was not signi®cantly dierent from that of the two neo clones (35.1+3%). As previously reported (Strobel et al., 1996) , BAX overexpressing cells were more sensitive to the cytotoxic eects of paclitaxel when compared to neo-control cells (Figure 4b ).
Discussion
It has been suggested that the p53 protein may partly mediate apoptosis through its ability to upregulate BAX and downregulate BCL-2 expression (Haldar et al., 1994; Miyashita et al., 1994; Selvakumaran et al., 1994) . Evidence in support of this concept is derived from the fact that the BAX promoter contains four p53 consensus binding sites and is capable of driving transcription of a CAT reporter construct in the presence of wildtype p53 (Miyashita et al., 1995) . Furthermore, expression of wildtype p53 in the p53-de®cient M1 murine leukemia cell line is associated with increased BAX levels, and p53-de®cient mice have been shown to express markedly lower levels of BAX in certain organ sites such as the central and peripheral nervous system, prostate, and small bowel . The fact that an association has been observed between the upregulation of BAX and the development of apoptosis in cells containing wildtype p53 has supported the concept that BAX may be a major downstream eector of p53. Despite the noted association between p53, BAX upregulation, and apoptosis, it is becoming more generally appreciated that restoration of wildtype p53 at either 328 or 378C, followed by immunoblot analysis as described. As expected, p21/WAF-1 is induced at the permissive temperature, although no signi®cant upregulation of BAX (also migrating at 21 kDa) was detected (con®rmed by densitometry analysis). In addition, there was no downregulation of BCL-2 (26 kDa) or BCL-xL (30 kDa) at the permissive temperature. An unidenti®ed faster migrating band of uncertain signi®cance was sometimes observed to co-migrate with BCL-x L in cells exposed to the permissive temperature. (b) SW626 clone tsp53 H10 was pre-incubated at 328C for 18 h, followed by exposure to 1000 rads (time 0) and assessment by immunoblot analysis over a 72 h incubation period (328C) as indicated. No signi®cant upregulation of BAX or downregulation of BCL-2 or BCL-xL was observed after irradiation as con®rmed by densitometry analysis p53 and BAX in radiation-induced apoptosis T Strobel et al function does not always lead to induction of apoptosis. Our data are in agreement with those of others who have failed to demonstrate G 1 arrest or apoptosis in cells induced to express wildtype p53, despite the presence of p21 upregulation (Eliopoulos et al., 1995; Kobayashi et al., 1995) . The fact that p21 was induced at the permissive temperature suggests that sucient levels of functional p53 were expressed in SW626 cells to permit a biological eect. Thus, it is unlikely that an inactivating mutation acquired by the tsp53 cDNA construct or a dominant negative eect from endogenous p53 was responsible for the lack of p53-mediated apoptosis observed in our study. In contrast to a previous report , we did not ®nd evidence for alterations in BAX, BCL-2, or BCL-x L upon expression of wildtype p53, in the presence or absence of genotoxic damage induced by radiation. Thus, the presence of wildtype p53 is not sucient to upregulate BAX (or downregulate BCL-2) levels during apoptosis in certain cell types, suggesting that the ability of p53 to regulate BAX transcription may be cell lineage dependent. This conclusion is also supported by the observation that BAX expression was preserved at normal levels in many (but not all) tissues in p53-de®cient mice . Alternatively, it is possible that a survival advantage may be conferred to cells acquiring mutations in the BAX promoter which render this gene resistant to p53 transactivation.
During the course of these experiments, we considered the possibility that the observed inability of p53 to mediate apoptosis in SW626 cells (with or without radiation) was related to the lack of p53-induced BAX upregulation. In order to directly address this issue, we assessed the eects of stable BAX overexpression, which resulted in tenfold higher BAX levels that in neo-control SW626 cells, on induction of apoptosis in response to radiation. Interestingly, BAX overexpression did not lower the apoptotic threshold of SW626 cells in response to radiation, although the sensitivity of these cells to microtubule damaging agents such as paclitaxel was dramatically enhanced. The ability of BAX to enhance apoptosis in response to paclitaxel is consistent with our previous observations and demonstrates that the BAX expressed by these cells was functional. In this regard, BAX has been previously shown to enhance the cytotoxicity of other microtubule poisons such as vincristine, but was not capable of enhancing killing by DNA damaging agents such as carboplatin and etoposide (Strobel et al., 1996) . In addition, thymocytes obtained from BAX-de®cient knockout mice are known to be equally sensitive to ionizing radiation when compared to cells expressing normal levels of BAX (Knudson et al., 1995) . Thus, it appears that BAX is not a necessary downstream mediator of radiation-induced apoptosis under all circumstances. In summary, we have observed that either restoration of wildtype p53 function or overexpression of BAX does not promote apoptosis in response to ionizing radiation in SW626 cells. These observations raise the possibility that p53 and BAX do not simply function sequentially, but instead may be required together for the generation of an apoptotic response to genotoxic damage. Double transfection of SW626 cells with both wildtype p53 and BAX will be necessary to investigate this possibility. The role of other related death proteins such as BIK and BAK in the process of p53 and BAX-mediated apoptosis also deserves further study (Boyd et al., 1995; Chittenden et al., 1995) .
Materials and methods

Source of cells and reagents
The SW626 human ovarian epithelial carcinoma cell line used for transfection and drug sensitivity studies was obtained from the American Type Culture Collection (Rockville, MD). We have determined that the p53 gene of this cell line harbors a G-to-A mutation at codon 245, resulting in a glycine-to-serine substitution. This is consistent with our previous report demonstrating inability to transactivate p21 in SW626 cells upon treatment with ionizing radiation (Strobel et al., 1996) . Cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM, Sigma Chemical Company, St Louis, MO) supplemented with 10% fetal calf serum (FCS) (HyClone, Logan, UT). Propidium iodide (PI) used for assessment of DNA content was purchased from Sigma. Paclitaxel was purchased from Bristol-Myers Squibb (Princeton, NJ). The previously described plasmid encoding the temperature-sensitive (ts) val135 mutant of p53 under the control of the Harvey sarcoma virus long terminal repeat was a kind gift of Dr Moshe Oren (Weizmann Institute, Rehovot, Israel) (Yonish-Rouach et al., 1991) . This temperature sensitive p53 mutant is known to exhibit wildtype function at the permissive temperature of 328C. Murine BAX cDNA present in an hemagglutinin (HA)/pSFFV-expression vector (HA-BAX) has been previously reported (Oltvai et al., 1993) . The plasmid encoding for neomycin resistance (pSV2-neo) was a kind gift of Dr Michel Streuli, DanaFarber Cancer Institute (DFCI). Geneticin (G418) used for selection of neomycin resistance during transfection studies was purchased from Life Technologies, Inc. (Gaithersburg, MD).
Generation of stable transfectants expressing tsp53 or HA-BAX
Lipofection was used to generate stable SW626 clones expressing either pSV2-neo alone, tsp53, or HA-BAX. SW626 cells were grown to 50% con¯uence in the presence of 10% FCS/DMEM in 35 mm diameter tissue culture dishes. For each lipofection, 2 mg total of DNA (10 : 1 ratio of tsp53 or HA-BAX : pSV2-neo cDNA) was added to 100 ml of serum-free medium (SFM) comprised of Iscove's modi®ed Dulbecco's medium (IMDM) containing 1 mg/ml insulin, 5 mM transferrin, 10 mg/ml cholesterol (Sigma), followed by addition of 110 ml of lipofectAMINE solution (Life Technologies, Inc) . After incubation at RT for 45 min, 800 ml of SFM was added to the DNA mixture, bringing the total volume to &1 ml. The adherent cells were washed twice in SFM, followed by addition of the 1 ml DNA mixture to the culture dish. After incubation for 6 h (378C, 5% CO 2 ), the cells were washed once in 10% FCS/DMEM (without antibiotics), followed by addition of 2 ml of the same medium. After an 18 h incubation (378C, 5% CO 2 ), the medium was replaced with fresh 10% FCS/ DMEM, containing 50 U/ml of penicillin and streptomycin. After an additional 24 h incubation at 378C, fresh medium was provided containing 500 mg/ml G418, followed by continued incubation for up to 3 weeks during which neomycin-resistant cells were identi®ed and cloned by limiting dilution.
Antibodies
Primary antibodies used for characterization of SW626 transfectants in immunoblot analysis are as follows: Murine anti-human p53 monoclonal antibody (clone PAb240, 1 : 2000 dilution, Oncogene Science, Cambridge, MA); rabbit anti-human p21 (clone C19, 1 : 1000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA); rabbit antihuman BAX polyclonal AB (clone P19, 1 : 1000 dilution, Santa Cruz Biotechnology); murine anti-human BCL-2 (clone 124, 1 : 1000 dilution, Dako Corporation, Santa Barbara, CA); rabbit anti-human BCL-x L (1 : 1000 dilution, clone S18, Santa Cruz Biotechnology); murine anti-human tubulin (clone DM1-alpha, 1 : 10000 dilution, Sigma). Secondary antibodies were either goat anti-rabbit-Ig conjugated to horseradish peroxidase (HRPO)(1 : 3000 dilution, Caltag Laboratories, South San Francisco, CA) or sheep anti-mouse Ig conjugated to HRPO (1 : 5000 dilution, Amersham Life Sciences, Arlington Heights, IL) as appropriate.
Immunoblotting
Lysates (50 mg/lane) were resolved by one-dimensional SDS-polyacrylamide gel electrophoresis (SDS ± PAGE) under reducing conditions, followed by transfer onto a 0.45 mm PVDF membrane (Millipore Corporation, Bedford, MA) in transfer buer at 0.2 amp for 2 h. After transfer, residual binding sites were blocked by incubating the membrane in Tris buered saline (TBS) containing 10% nonfat dry milk for 1 hr at RT. The blots were then incubated with the appropriate primary antibody in TBS with 0.05% Tween-20 (TBST) containing 5% nonfat dry milk for 16 h at 48C. The blots were then washed three times for 10 min in TBST, followed by incubation with the secondary antibody conjugated to HRPO in TBST containing 5% nonfat dry milk for 1 hr at RT. After three washes for 10 min in TBST, the blots were developed using the enhanced chemiluminescence (ECL) detection system (Amersham) according to the manufacturer's protocol and exposed to X-ray ®lm (Eastman Kodak).
Assessment of sub-G 0 DNA content by propidium iodide staining
The fraction of cells containing a sub-G 0 DNA content has been shown to correlate with apoptotic cell death and was quantitated by¯ow cytometry as previously described (Strobel et al., 1996) . Brie¯y, 0.5610 6 cells per sample were pelletted and resuspended in 50 mg/ml PI (Sigma) in 0.1% sodium citrate and 0.1% Nonidet P40 (NP40), resulting in lysis of the cell membrane while maintaining integrity of the nucleus. After a 10 min incubation at RT, 1610 4 cells per sample were analysed by¯ow cytometry on an Epics V cell sorter, with assessment of the fraction of cells present in the sub G 0 /G 1 peak.
Cytotoxicity assay
The relationship between radiation or drug dose and cytotoxicity was determined for selected SW626 transfectants in suspension culture. Where indicated, SW626 clones expressing tsp53 mutant were incubated for 18 h at 328C prior to radiation or paclitaxel treatment, followed by continued incubation at 328C for the duration of the p53 and BAX in radiation-induced apoptosis T Strobel et al experiment. Cells were seeded (2.5610 4 /well) in 24 well plates (Falcon, Oxnard, CA) in 10% FCS/DMEM after radiation or in the continued presence of paclitaxel over a broad concentration range, followed by incubation (378C, 5% CO 2 ) and assessment of viable cell numbers by trypan blue exclusion at day 3. Cell counts were performed in duplicate for each drug dose and time point, with the standard error of the mean typically being less than 15%. The percent survival was de®ned as 1006 [viable cell number (radiation or drug) /viable cell number (medium alone) at the identical time point.
